Showing results (51-60 of 1,431) with videos related to
Sort By:
Pageof 144
The Journal of Urology|August 1, 1991
Elevated plasma chromogranin-A concentrations in prostatic carcinomaD Kadmon, T C Thompson, G R Lynch, et al.Molecular and Cellular Endocrinology|September 1, 1987
Androgen-regulated expression of secretory protein synthesis in mouse ventral prostateJ S Mills, M Needham, T C Thompson, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 5, 1998
Induction of labyrinthitis ossificans after pneumococcal meningitis: an animal modelH A Brodie, T C Thompson, L Vassilian, et al.Cell|July 10, 1992
Ras-induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutationX Lu, S H Park, T C Thompson, et al.Prostate Cancer and Prostatic Diseases|July 8, 2009
The role of caveolin-1 in prostate cancer: clinical implicationsT C Thompson, S A Tahir, L Li, et al.Journal of Steroid Biochemistry|November 1, 1986
Androgen-induced biochemical responses in epithelium lacking androgen receptors: characterization of androgen receptors in the mesenchymal derivative of urogenital sinusT C Thompson, G R Cunha, J M Shannon, et al.Oncogene|August 19, 2014
DNA damage response and prostate cancer: defects, regulation and therapeutic implicationsS Karanika, T Karantanos, L Li, et al.The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1995
Progression to androgen insensitivity in a novel in vitro mouse model for prostate cancerP A Baley, K Yoshida, W Qian, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancerY Nasu, C H Bangma, G W Hull, et al.Oncogene|December 26, 2001
LAPSER1: a novel candidate tumor suppressor gene from 10q24.3Y Cabeza-Arvelaiz, T C Thompson, J L Sepulveda, et al.Pageof 144